BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Policy

  Novartis AG Plant To Fall Under GlaxoSmithKline Control

  July 18, 2014

   · 

  1 min read
• Deals

  Gentiva Health Services Grabs $634 Million Bid, Rejects Kindred Bio’s Stake Offer

  July 18, 2014

   · 

  7 min read
• Drug Development

  Genmab A/S Announces Phase 3 Study Of Daratumumab In Front Line Multiple Myeloma

  July 18, 2014

   · 

  4 min read
• Policy

  Federal Court Holds Manufacturer Of Investigational Drug And Medical Device Responsible For Clinical Trial Investigator’s Allegedly Inadequate Informed Consent Form

  July 18, 2014

   · 

  1 min read
• Drug Development

  Regeneron Pharmaceuticals, Inc. Release: Two-Year Results From Phase 3 VIVID-DME Trial Of EYLEA® (aflibercept) Injection For The Treatment Of Diabetic Macular Edema Show Sustained Improvement In Vision

  July 18, 2014

   · 

  13 min read
• Policy

  White House Puts Up Roadblock To Stop Medtronic, Inc.'s Irish Tax Strategy

  July 18, 2014

   · 

  1 min read
• Pharm Country

  Parkinson’s Disease Foundation Awards $1.3 Million In Research Grants To Help Solve, Treat And End Parkinson’s Disease

  July 18, 2014

   · 

  10 min read